ABUS — ARBUTUS BIOPHARMA CORP

Ownership history in PRUDENTIAL FINANCIAL INC  ·  14 quarters on record

This page tracks every 13F SEC filing in which PRUDENTIAL FINANCIAL INC reported a position in ARBUTUS BIOPHARMA CORP (ABUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 18,255 — 0% 0.00% $83K $4.54
2025 Q2 ADDED 18,255 +7,610 +71.5% 0.00% $56K $3.09
2025 Q1 REDUCED 10,645 -4,330 -28.9% 0.00% $37K $3.49
2024 Q2 ADDED 14,975 +2,390 +19.0% 0.00% $46K $3.09
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ABUS price (monthly, adj. close)

Other funds also holding ABUS

As of 2025 Q4 — sorted by position size

Whitefort Capital Management, LP 3Y 16.41% Rangeley Capital, LLC 3.36% ADAR1 Capital Management, LLC 1.89% Two Seas Capital LP 3Y 1.25% Western Standard LLC 3Y 7Y 1.13% STEMPOINT CAPITAL LP 0.81% BlackBarn Capital Partners LP 0.59% SHERBROOKE PARK ADVISERS LLC 3Y 0.35% AlphaCentric Advisors LLC 3Y 0.23% Murchinson Ltd. 3Y 0.21%
← Back to PRUDENTIAL FINANCIAL INC Holdings